BACKGROUND: FoxP3/CD4/CD25 regulatory T cells (Treg) play an important role in maintaining peripheral tolerance and are potent suppressors of T-cell activation. In this study, we evaluated the role of Treg in peripheral tolerance to composite tissue allografts (CTA). METHODS: Mixed allogeneic chimeric rats were prepared by preconditioning recipients with anti-αβ-T-cell receptor monoclonal antibody followed by total body irradiation. Animals received T-cell-depleted August Copenhagen Irish bone marrow cells followed by antilymphocyte serum and FK-506. A modified osteomyocutaneous hindlimb flap composed of bone and all limb tissue components was placed in animals with chimerism greater than or equal to 1% on day 28. Recipients with CTA surviving more than or equal to 6 months were evaluated for Treg. Skin samples from tolerant long-term allogeneic transplanted, syngeneic transplanted, rejected, and naïve animals were immunostained with fluorochrome-conjugated anti-FoxP3 and anti-CD4 monoclonal antibody and visualized under a laser confocal microscope. RESULTS: Significant CD4/FoxP3 Treg infiltrates were observed in tolerant donor-allograft skin samples. No graft infiltrating FoxP3 cells were observed in rejector, naïve, or skin from syngeneic CTA. In parallel experiments, mixed leukocyte reaction assays were performed to investigate the suppressor function of Treg cells. Splenocytes from tolerant, rejected, and naïve rats were sorted by flow cytometry for CD4/CD25 T cells. Treg demonstrated similar suppressive levels between the three groups. CONCLUSIONS: These data suggest that Treg may play an important role in maintenance of tolerance and promoting graft acceptance in long-term CTA acceptors and may explain the favorable outcomes observed in clinical CTA recipients.
BACKGROUND:FoxP3/CD4/CD25 regulatory T cells (Treg) play an important role in maintaining peripheral tolerance and are potent suppressors of T-cell activation. In this study, we evaluated the role of Treg in peripheral tolerance to composite tissue allografts (CTA). METHODS: Mixed allogeneic chimeric rats were prepared by preconditioning recipients with anti-αβ-T-cell receptor monoclonal antibody followed by total body irradiation. Animals received T-cell-depleted August Copenhagen Irish bone marrow cells followed by antilymphocyte serum and FK-506. A modified osteomyocutaneous hindlimb flap composed of bone and all limb tissue components was placed in animals with chimerism greater than or equal to 1% on day 28. Recipients with CTA surviving more than or equal to 6 months were evaluated for Treg. Skin samples from tolerant long-term allogeneic transplanted, syngeneic transplanted, rejected, and naïve animals were immunostained with fluorochrome-conjugated anti-FoxP3 and anti-CD4 monoclonal antibody and visualized under a laser confocal microscope. RESULTS: Significant CD4/FoxP3Treg infiltrates were observed in tolerant donor-allograft skin samples. No graft infiltrating FoxP3 cells were observed in rejector, naïve, or skin from syngeneic CTA. In parallel experiments, mixed leukocyte reaction assays were performed to investigate the suppressor function of Treg cells. Splenocytes from tolerant, rejected, and naïve rats were sorted by flow cytometry for CD4/CD25 T cells. Treg demonstrated similar suppressive levels between the three groups. CONCLUSIONS: These data suggest that Treg may play an important role in maintenance of tolerance and promoting graft acceptance in long-term CTA acceptors and may explain the favorable outcomes observed in clinical CTA recipients.
Authors: Yiming Huang; Francine Rezzoug; Paula M Chilton; H Leighton Grimes; Daniel E Cramer; Suzanne T Ildstad Journal: Blood Date: 2004-03-30 Impact factor: 22.113
Authors: Helmut Jonuleit; Edgar Schmitt; Hacer Kakirman; Michael Stassen; Jürgen Knop; Alexander H Enk Journal: J Exp Med Date: 2002-07-15 Impact factor: 14.307
Authors: David W Mathes; Billanna Hwang; Scott S Graves; James Edwards; Jeff Chang; Barry E Storer; Tiffany Butts-Miwongtum; George E Sale; Richard A Nash; Rainer Storb Journal: Transplantation Date: 2011-12-27 Impact factor: 4.939
Authors: James D Fisher; Wensheng Zhang; Stephen C Balmert; Ali M Aral; Abhinav P Acharya; Yalcin Kulahci; Jingjing Li; Heth R Turnquist; Angus W Thomson; Mario G Solari; Vijay S Gorantla; Steven R Little Journal: Sci Adv Date: 2020-03-13 Impact factor: 14.136
Authors: Abbas Shahi; Saeedeh Salehi; Shima Afzali; Ladan Gol Mohammad Pour Afrakoti; Marzie Esmaeili; Farzaneh Bagherpour; Ziba Aghsaeifard; Sanaz Dehghani; Gholamreza Pourmand; Ali Akbar Amirzargar Journal: Biomed Res Int Date: 2021-02-09 Impact factor: 3.411